<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2026-02-04 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2026-02-04/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2026-02-04"><meta property="og:description" content="ğŸ“… Daily Report - 2026-02-04 ä»Šæ—¥ç­›é€‰å‡º 60 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2026-02-04T00:00:00+00:00"><meta property="article:modified_time" content="2026-02-04T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week062026"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2026-02-04"><meta itemprop=description content="ğŸ“… Daily Report - 2026-02-04 ä»Šæ—¥ç­›é€‰å‡º 60 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2026-02-04T00:00:00+00:00"><meta itemprop=dateModified content="2026-02-04T00:00:00+00:00"><meta itemprop=wordCount content="1676"><meta itemprop=keywords content="Research,Daily,Week062026"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2026-02-04"><meta name=twitter:description content="ğŸ“… Daily Report - 2026-02-04 ä»Šæ—¥ç­›é€‰å‡º 60 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-04</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2026-02-04T00:00:00Z>2026-02-04</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2026-02-04>ğŸ“… Daily Report - 2026-02-04</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>60</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
ç©ºé—´è½¬å½•ç»„å­¦ä¸å•ç»†èƒæµ‹åºç»“åˆï¼Œæ­ç¤ºäº†Lars2åœ¨å°é¼ å¿ƒè„é‡å¡‘çš„æ—¶ç©ºåŠ¨æ€æœºåˆ¶ï¼›æ•´åˆè‚¿ç˜¤å…ç–«ç»†èƒä¸æŠ—ä½“ç–—æ³•ï¼Œé©±åŠ¨äº†æŠ—è‚¿ç˜¤å…ç–«ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>è‚¿ç˜¤å…ç–«ä¸æ²»ç–—</strong>ï¼šæ¢ç´¢å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­ç–—æ³•æŠµæŠ—æœºåˆ¶ï¼Œå¼€å‘è‚¿ç˜¤ç‰¹å¼‚æ€§å…ç–«ç»†èƒå’ŒæŠ—ä½“ç–—æ³•ï¼Œä»¥åŠGLIOMBAç­‰è‚¿ç˜¤çš„å…ç–«å¾®ç¯å¢ƒç ”ç©¶ã€‚</li><li><strong>å…ç–«ç»†èƒåŠŸèƒ½ä¸è°ƒæ§</strong>ï¼šç ”ç©¶TOXå¯¹TH1 CD4+ Tç»†èƒæ•ˆåº”åŠŸèƒ½çš„å½±å“ï¼ŒMHC Iåœ¨CD4+ Tç»†èƒä»‹å¯¼å…ç–«ä¸­çš„ä½œç”¨ï¼Œä»¥åŠIL-22åœ¨3å‹å…ç–«ç»†èƒä¸­çš„é¡ºå¼è°ƒæ§ã€‚</li><li><strong>ç–¾ç—…æ¨¡å‹ä¸æœºåˆ¶</strong>ï¼šåˆ©ç”¨ç©ºé—´è½¬å½•ç»„å­¦è§£æAPOE4ç­‰åŸºå› åœ¨é˜¿å°”èŒ¨æµ·é»˜ç—…å’Œå¸•é‡‘æ£®ç—…æ¨¡å‹ä¸­çš„ä½œç”¨ï¼Œä»¥åŠå¿ƒè¡€ç®¡ç–¾ç—…ï¼ˆå¦‚å¿ƒè‚Œç—…ã€åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ï¼‰çš„åˆ†å­æœºåˆ¶ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>å¤šç»„å­¦æ•´åˆåˆ†æ</strong>ï¼šç»“åˆç©ºé—´è½¬å½•ç»„å­¦ã€å•ç»†èƒRNAæµ‹åºã€è›‹ç™½ç»„å­¦ç­‰æŠ€æœ¯ï¼Œå®ç°å¯¹å¤æ‚ç”Ÿç‰©è¿‡ç¨‹çš„æ·±åº¦è§£æã€‚</li><li><strong>æ–°å‹å…ç–«ç–—æ³•ç­–ç•¥</strong>ï¼šé€šè¿‡é¶å‘è¡€ç®¡å¹³æ»‘è‚Œç»†èƒã€è®¾è®¡æ‚åˆèƒ°å²›ç´ è‚½ç­‰ï¼Œæ¢ç´¢æ–°çš„æŠ—è‚¿ç˜¤å’Œè‡ªèº«å…ç–«æ€§ç–¾ç—…æ²»ç–—é€”å¾„ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
SeekGeneæ¨å‡ºé¦–ä¸ªæ•´åˆDNAç”²åŸºåŒ–ã€RNAæµ‹åºä¸å…ç–«è°±ç³»åˆ†æçš„é«˜é€šé‡å•ç»†èƒå¤šç»„å­¦è§£å†³æ–¹æ¡ˆã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ¢ç´¢Reelinè›‹ç™½åœ¨ç¼“è§£æ…¢æ€§å‹åŠ›è¯±å¯¼çš„è‚ é“å±éšœæŸä¼¤åŠæŠ‘éƒç—‡ä¸­çš„ä½œç”¨ã€‚</li><li>ä¼˜åŒ–å•ç»†èƒRNAæµ‹åºåˆ†ææ¨¡å‹ï¼Œé€šè¿‡å¼•å…¥å±‚çº§äº¤å‰ç†µæŸå¤±æå‡å¤§è§„æ¨¡ç»†èƒå›¾è°±æ³¨é‡Šç²¾åº¦ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>é¦–æ¬¡å®ç°å•ç»†èƒæ°´å¹³DNAç”²åŸºåŒ–ä¸RNAå¤šç»„å­¦çš„é«˜é€šé‡æ•´åˆåˆ†æã€‚</li><li>æå‡ºåˆ©ç”¨ç”Ÿç‰©å­¦ç»†èƒå±‚çº§å…³ç³»æ”¹è¿›å•ç»†èƒRNAæµ‹åºæ³¨é‡Šæ¨¡å‹ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (57æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE308859 æ•´åˆç©ºé—´è½¬å½•ç»„å­¦å’Œå•ç»†èƒ RNA æµ‹åºæ­ç¤º Lars2 ä»‹å¯¼çš„å°é¼ æ¨ªå‘ä¸»åŠ¨è„‰ç¼©çª„ (TAC) æ¨¡å‹ä¸­å¿ƒè‚Œé‡å¡‘çš„æ—¶ç©ºåŠ¨æ€</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cellã€spatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Hanwen Ni ; Feng Liang ; Huanhuan Huo ; Xuechao Feng ; Ben HeSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusMulti-omics approaches have emerged as a cornerstone in medical biology, offering an integrative perspective on tissue and cellular composition, gene expression patterns, functional states, and metabolic dynamics. In this study, we employed multi-omics methodologies, combining spatial transcriptomics (ST) and single-cell RNA sequencing (scRNA-seq), to perform large-scale bioinformatics analysis on heart samples from Transverse Aortic Constriction (TAC) mouse models at various stages of disease progression. The aim was to investigate the spatial and temporal characteristics of cellular distribution, gene composition, and associated functional changes within the myocardium in response to pressure overload. For the first time, the pathophysiology of myocardial hypertrophy in this model is described through the integrated lens of spatial and single-cell transcriptomics. The spatial transcriptomics analysis revealed a uniform cellular distribution across the heart tissue in TAC mice at different disease stages. However, substantial shifts in cellular composition were observed, with the most significant alterations occurring in cluster 1, which primarily involved changes in fibroblasts and macrophages. Single-cell RNA sequencing further demonstrated that the most notable changes in cellular composition occurred at the TAC-4W stage, characterized by a reduction in fibroblast and macrophage populations and an increase in immune cell subsets, such as neutrophils and T cells. By TAC-6W, the cellular composition returned to a state comparable to that observed at TAC-2W. Further analysis integrating both spatial and single-cell transcriptomes highlighted cluster 1 as the site of the most prominent microenvironmental changes, predominantly involving T cells and macrophages. Notably, the genes Lef1, Ccr7, Sell, and Lars2 were identified as significantly differentially expressed in these cellsâ€”an observation not previously reported. In particular, the expression of Lars2 exhibited dynamic modulation throughout disease progression. While its expression at TAC-2W did not differ significantly from controls, Lars2 expression peaked at TAC-4W, only to decline at TAC-6W. This study provides a comprehensive characterization of myocardial hypertrophy in the TAC mouse model, leveraging the power of spatial trans&mldr;</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308859">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE302765 è‚¿ç˜¤ç‰¹å¼‚æ€§æ ‘çªçŠ¶ç»†èƒå’ŒæŠ—ä½“ç–—æ³•åœ¨è‚¿ç˜¤å†…çš„æ•´åˆé©±åŠ¨å…ˆå¤©æ€§å’Œé€‚åº”æ€§æŠ—ç™Œå…ç–« [PanCancer_IO360_NanoString]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€dendritic cellã€antibody</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Saurabh Garg ; Brian CzernieckiSeries Type : Expression profiling by arrayOrganism : Mus musculusComparison of gene expression profiles of HER2+ murine mammary carcinoma treated with HER2 DC1, anti-Sema4D, and combination of both HER2 DC1 and anti-Sema4D therapy</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302765">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE302764 è‚¿ç˜¤ç‰¹å¼‚æ€§æ ‘çªçŠ¶ç»†èƒå’ŒæŠ—ä½“ç–—æ³•åœ¨è‚¿ç˜¤å†…çš„æ•´åˆé©±åŠ¨å…ˆå¤©æ€§å’Œé€‚åº”æ€§æŠ—ç™Œå…ç–« [Immunology_NanoString]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€dendritic cellã€antibody</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Saurabh Garg ; Brian CzernieckiSeries Type : Expression profiling by arrayOrganism : Mus musculusComparison of gene expression profiles of HER2+ murine mammary carcinoma treated with HER2 DC1, anti-Sema4D, and combination of both HER2 DC1 and anti-Sema4D therapy</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302764">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE302763 è‚¿ç˜¤ç‰¹å¼‚æ€§æ ‘çªçŠ¶ç»†èƒå’ŒæŠ—ä½“ç–—æ³•åœ¨è‚¿ç˜¤å†…çš„æ•´åˆé©±åŠ¨å…ˆå¤©æ€§å’Œé€‚åº”æ€§æŠ—ç™Œå…ç–« [Myeloid_Innate_Immunity_NanoString]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€dendritic cellã€antibody</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Saurabh Garg ; Brian CzernieckiSeries Type : Expression profiling by arrayOrganism : Mus musculusComparison of gene expression profiles of HER2+ murine mammary carcinoma treated with HER2 DC1, anti-Sema4D, and combination of both HER2 DC1 and anti-Sema4D therapy</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302763">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE302735 è‚¿ç˜¤ç‰¹å¼‚æ€§æ ‘çªçŠ¶ç»†èƒå’ŒæŠ—ä½“ç–—æ³•åœ¨è‚¿ç˜¤å†…çš„æ•´åˆé©±åŠ¨å…ˆå¤©æ€§å’Œé€‚åº”æ€§æŠ—ç™Œå…ç–« [Metabolic_Pathways_NanoString]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€dendritic cellã€antibody</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Garg Saurabh ; Czerniecki BrianSeries Type : Expression profiling by arrayOrganism : Mus musculusComparison of gene expression profiles of HER2+ murine mammary carcinoma treated with HER2 DC1, anti-Sema4D, and combination of both HER2 DC1 and anti-Sema4D therapy</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302735">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE317909 TOX é©±åŠ¨ TH1 CD4+ T ç»†èƒæ•ˆåº”åŠŸèƒ½ã€æŠ—è‚¿ç˜¤å…ç–«å’Œè‡ªèº«å…ç–«æ€§ç–¾ç—…çš„è‡´ç—…æ€§ [RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cellã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Andrea Schietinger ; Brianna Naizir ; Andrew Scott ; Doron Betel ; Paul ZumboSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusRNA-seq analysis of TOX WT and TOX KO transgenic (TCRSMARTA) CD4 T cells from tdLN of tumor-bearing mice day 11 post transfer</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317909">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE301073 ä¸åŒçš„è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒ (TIME) ç‰¹å¾é©±åŠ¨èƒ¶è´¨æ¯ç»†èƒç˜¤ä¸­ä¸åŒçš„å…ç–«æ²»ç–—ååº”</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immuneã€regex:immuno(logy|therapy|suppression)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Linqian Weng ; Krish Skandha Gopalan ; Gabriele BergersSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusGlioblastoma (GBM) exhibits significant molecular heterogeneity leading to variable treatment responses. Despite multimodal therapies, prognosis remains poor, highlighting the need for personalized approaches targeting the tumor immune microenvironment (TIME). Using single-cell RNA sequencing, multiplex immunohistochemistry, and orthotopic mouse models, we characterized distinct TIME subtypes and evaluated responses to anti-angiogenic immunotherapy and myeloid-targeting approaches. We identified three TIME subtypes: TIME-low (immune-excluded with abnormal vasculature), TIME-med (immune-infiltrated with functional T cells), and TIME-high (heavily infiltrated with immunosuppressive myeloid cells and anergic T cells). TIME-low GBMs responded transiently to anti-angiogenic immunotherapy with immunostimulatory T cell shifts, while anti-angiogenic therapy was ineffective in TIME-high GBMs due to immunosuppressive myeloid cells. CD40 agonist treatment worsened outcomes in TIME-high GBMs by increasing immunosuppressive cells and reducing NK recruitment. Conversely, PI3KÎ³/Î´ inhibition combined with anti-angiogenic immunotherapy modestly extended survival in TIME-high tumors. Our study reveals that GBM subtypes require tailored therapeutic strategies, with TIME classification potentially predicting treatment responses and TIME-high tumors requiring myeloid reprogramming to overcome immunosuppression.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301073">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>GSE273583 è½¬ç§»æ€§é»‘è‰²ç´ ç˜¤å¯¹å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­ç–—æ³•çš„å…ˆå¤©æ€§å’Œè·å¾—æ€§è€è¯æ€§çš„ç»¼åˆè›‹ç™½è´¨åŸºå› ç»„å­¦å’Œç©ºé—´åˆ†æ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€resistanceã€spatial</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Shiyou wei ; Kuang Du ; Hongbin Lan ; Zhenyu Yang ; Yulan Deng ; Zhi Wek ; Dennie T Frederick ; Jinho Lee ; Marilyne Labrie ; Tian Tian ; Tabea Moll ; Yeqing Chen ; Ryan J Sullivan ; Gordon Mills ; Genevieve M Boland ; Keith T Flaherty ; Lunxu Liu ; Meenhard Herlyn ; Gao ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensWhile a subset of patients with metastatic melanoma achieves durable responses to immune checkpoint blockade (ICB) therapies, the majority ultimately exhibit either innate or acquired resistance to these treatments. However, the molecular mechanisms underlying resistance to ICB therapies remain elusive and are warranted to elucidate. Here, we comprehensively investigated the tumor and tumor immune microenvironment (TIME) of paired pre- and post-treatment tumor specimens from metastatic melanoma patients who were primary or secondary resistance to anti-CTLA-4 and/or anti-PD-1/PD-L1 therapies. Differentially expressed gene (DEG) analysis and single-sample gene set enrichment analysis (ssGSEA) with transcriptomic data identified cell cycle and c-MYC signaling as pathway-based resistance signatures. And weighted gene co-expression network analysis (WGCNA) revealed the activation of a cross-resistance meta-program involving key signaling pathways related to tumor progression in ICB resistant melanoma. Moreover, spatially-resolved, image-based immune monitoring analysis by using NanoStringâ€™s digital spatial profiling (DSP) and Cyclic Immunofluorescence (CyCIF) showed infiltration of suppressive immune cells in the tumor microenvironment of melanoma with resistance to ICB therapies. Our study reveals the molecular mechanisms underlying resistance to ICB therapies in patients with metastatic melanoma by conducting such integrated analyses of multi-dimensional data, and provides rationale for salvage therapies that will potentially overcome resistance to ICB therapies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273583">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>GSE317910 TOX é©±åŠ¨ TH1 CD4+ T ç»†èƒæ•ˆåº”åŠŸèƒ½ã€æŠ—è‚¿ç˜¤å…ç–«å’Œè‡ªèº«å…ç–«æ€§ç–¾ç—…çš„è‡´ç—…æ€§ [CUT&amp;RUN]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Simon Grassmann ; Brianna Naizir ; Paul Zumbo ; Doron Betel ; Andrea SchietingerSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusCUT&amp;RUN analysis of CD4 and CD8 T cells (confirmed to express TOX)</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317910">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>GSE317904 TOX é©±åŠ¨ TH1 CD4+ T ç»†èƒæ•ˆåº”åŠŸèƒ½ã€æŠ—è‚¿ç˜¤å…ç–«ä»¥åŠè‡ªèº«å…ç–«æ€§ç–¾ç—…çš„è‡´ç—…æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Andrea Schietinger ; Brianna Naizir ; Andrew Scott ; Doron Betel ; Paul ZumboSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusATAC-seq analysis of TOX WT and TOX KO transgenic (TCRSMARTA) CD4 T cells from tdLN of tumor-bearing mice at day 11 post transfer</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317904">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 47 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨3æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4><p><strong>1.</strong> <strong>SeekGeneæ¨å‡ºé«˜é€šé‡å•ç»†èƒDNAç”²åŸºåŒ–+RNAå¤šç»„å­¦è§£å†³æ–¹æ¡ˆ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cellã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeekGene unveiled a high-throughput single-cell platform that integrates RNA sequencing with DNA methylation and immune profiling..</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/seekgene-launches-high-throughput-single-cell-dna-methylation-rna-multi-omics-solution/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>ç§‘å­¦å®¶å‘ç°ä¸€ç§è›‹ç™½è´¨ï¼Œå®ƒèƒ½ä¿®å¤è‚ æ¼å¹¶ç¼“è§£æŠ‘éƒç—‡ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šChronic stress can damage the gutâ€™s protective lining, triggering inflammation that may worsen depression. New research shows that stress lowers levels of a protein called Reelin, which plays a key role in both gut repair and brain health. Remarkably, a single injection restored Reelin levels and produced antidepressant-like effects in preclinical models. The findings hint at a future treatment that targets depression through the gutâ€“brain connection.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/02/260201231240.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>åˆ©ç”¨åˆ†å±‚äº¤å‰ç†µæŸå¤±æ”¹è¿›å›¾è°±å°ºåº¦å•ç»†èƒæ³¨é‡Šæ¨¡å‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šA new approach to RNA sequencing analysis shows that respecting biological cell hierarchies improves single-cell annotation accuracy, especially when models are applied to new&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/improving-atlas-scale-single-cell-annotation-models-with-hierarchical-cross-entropy-loss/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>tumor</td><td>13</td></tr><tr><td>regex:immuno(logy</td><td>therapy</td></tr><tr><td>cancer</td><td>9</td></tr><tr><td>immunity</td><td>8</td></tr><tr><td>RNA-seq</td><td>8</td></tr><tr><td>immune</td><td>7</td></tr><tr><td>T cell</td><td>6</td></tr><tr><td>single-cell</td><td>4</td></tr><tr><td>transcriptomics</td><td>4</td></tr><tr><td>genome</td><td>4</td></tr><tr><td>dendritic cell</td><td>4</td></tr><tr><td>antibody</td><td>4</td></tr><tr><td>spatial</td><td>3</td></tr><tr><td>sequencing</td><td>2</td></tr><tr><td>spatial transcriptomics</td><td>2</td></tr><tr><td>histone</td><td>2</td></tr><tr><td>Hi-C</td><td>2</td></tr><tr><td>ATAC-seq</td><td>2</td></tr><tr><td>scRNA</td><td>2</td></tr><tr><td>tumor microenvironment</td><td>2</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (47æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316959">GSE316959 é¶ç»†èƒä¸Šçš„ MHC I ç±»åˆ†å­è°ƒèŠ‚ CD4+ T ç»†èƒä»‹å¯¼çš„å…ç–«</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299087">GSE299087 æŠ—åŸç‰¹å¼‚æ€§å…ç–«ç–—æ³•åˆ©ç”¨CD4æ‚äº¤èƒ°å²›ç´ è‚½æ–°è¡¨ä½æŠ‘åˆ¶èƒ°å²›ç§»æ¤ä¸­CD8 Tç»†èƒçš„åˆ†åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293896">GSE293896 ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤º APOE4 ç­‰ä½åŸºå› å¯¹è·¯æ˜“ä½“ç—´å‘†ä¸­ Î±-çªè§¦æ ¸è›‹ç™½èšé›†å’Œç»†èƒé—´é€šè®¯çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308355">GSE308355 CLK1 é€šè¿‡æ¿€æ´» Hippo/YAP ä¿¡å·é€šè·¯ä¿ƒè¿› MDSC è¿ç§»å¹¶é‡ç¼–ç¨‹ç»“ç›´è‚ ç™Œè‚¿ç˜¤å¾®ç¯å¢ƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308264">GSE308264ï¼šRettç»¼åˆå¾iPSç»†èƒä¸­ç»„è›‹ç™½ä¿®é¥°H3K27acå’ŒCTCFè½¬å½•å› å­ç»“åˆçš„å…¨åŸºå› ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE246314">GSE246314 HEK293ç»†èƒç»VPAå¤„ç†åç»„è›‹ç™½ä¿®é¥°H3K27acå’ŒCTCFè½¬å½•å› å­ç»“åˆçš„å…¨åŸºå› ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245856">GSE245856 HEK293ç»†èƒç»VPAå¤„ç†åé‡‡ç”¨RNA-seqè¿›è¡Œå…¨åŸºå› ç»„åŸºå› è¡¨è¾¾è°±åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245848">GSE245848 HEK293ç»†èƒç»VPAå¤„ç†åï¼Œåˆ©ç”¨Hi-Cè¿›è¡Œå…¨åŸºå› ç»„æŸ“è‰²è´¨ç›¸äº’ä½œç”¨åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314572">GSE314572 3å‹å…ç–«ç»†èƒä¸­IL-22åŸºå› çš„é¡ºå¼è°ƒæ§[RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314555">GSE314555 IL-22 åŸºå› åœ¨ 3 å‹å…ç–«ç»†èƒä¸­çš„é¡ºå¼è°ƒæ§ [Chip-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314539">GSE314539 IL-22 åŸºå› åœ¨ 3 å‹å…ç–«ç»†èƒä¸­çš„é¡ºå¼è°ƒæ§ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE240148">GSE240148 å°é¼ ä½“å†…ç§»æ¤çš„B2M KO CD40å¤„ç†çš„B16è‚¿ç˜¤ä¸­è‚¿ç˜¤å¾®ç¯å¢ƒçš„è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314851">GSE314851 é€šè¿‡ FAP é¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [Visium]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317742">GSE317742 ä»è‚¿ç˜¤éƒ¨ä½è¿ç§»åˆ°èƒ¸è…ºçš„æ ‘çªçŠ¶ç»†èƒçš„ç‰¹å¾åˆ†æ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302512">GSE302512 Tç»†èƒè¡ç”Ÿçš„TNFé©±åŠ¨å¿ƒè‚Œç‚ï¼Œä½†å¯¹æ£€æŸ¥ç‚¹å…ç–«ç–—æ³•çš„æŠ—è‚¿ç˜¤ç–—æ•ˆå¹¶éå¿…éœ€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293887">GSE293887 é«˜çº§åˆ«æµ†æ¶²æ€§åµå·¢ç™Œå¾®ç¯å¢ƒçš„3Däº”é‡åŸ¹å…»æ¨¡å‹è½¬å½•ç»„å­¦</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318176">GSE318176 å¯¹ä¸åŒ SARS-CoV-2 ç–«è‹—æ¥ç§è€…å¤–å‘¨è¡€çš„æ•´åˆè¡¨è§‚åŸºå› ç»„å­¦å’Œè½¬å½•ç»„å­¦åˆ†ææ­ç¤ºäº† TGF-Î² ä»‹å¯¼çš„è€—ç«­æœºåˆ¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317457">GSE317457 ç³–åŸºåŒ–GM-CSFæ‰©å¢B-1bç»†èƒå’ŒB-1bæµ†ç»†èƒå¹¶ä½¿å…¶äº§ç”Ÿå…ç–«æŠ‘åˆ¶ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316800">GSE316800 æ‹‰ä¼¸é€šè¿‡ç›´æ¥æœºæ¢°æ•ˆåº”æŠ‘åˆ¶MMTV-PYMTä¸­çš„è‚¿ç˜¤ç”Ÿé•¿</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316197">GSE316197 NanoString ä¹³è…ºç™Œ 360 è¡¨è¾¾è°±åˆ†æï¼Œæ¥è‡ª NHBW å’Œ NHWW ä¾›ä½“çš„ç»„ç»‡å­¦æ­£å¸¸ä¹³è…ºå°å¶ (BC360)</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299250">GSE299250 L1CAM é€šè¿‡ NF-ÎºB æ¿€æ´»ä¿ƒè¿›äººç±»å­å®«å†…è†œç™Œçš„å‘ç”Ÿ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294707">GSE294707 æ¶ˆé™¤ DGCR8 è¡¨è¾¾å¯¹èƒšèƒç•¸èƒç˜¤ PA-1 ç»†èƒç¨³æ€ RNA æ°´å¹³çš„å½±å“ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314554">GSE314554 3 å‹å…ç–«ç»†èƒä¸­ IL-22 åŸºå› çš„é¡ºå¼è°ƒæ§ [ATAC-seq_Mnk3]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314532">GSE314532 3å‹å…ç–«ç»†èƒä¸­IL-22åŸºå› çš„é¡ºå¼è°ƒæ§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314278">GSE314278 åˆ©ç”¨æ–°å‹é€šç”¨Î³é“¾ç»†èƒå› å­èåˆåˆ†å­æ²»ç–—ç”ŸæˆæŒä¹…æ€§HIV CAR-TSCMç»†èƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314231">GSE314231 åŒ–ç–—è¯±å¯¼çš„ååº”æ€§é«“ç³»é€ è¡€å¯¼è‡´å°é¼ å’Œäººç±»å…ç–«æŠ‘åˆ¶æ€§ä¸­æ€§ç²’ç»†èƒæ ·å•æ ¸ç»†èƒæ‰©å¢ [scRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314047">GSE314047 åŒ–ç–—è¯±å¯¼çš„ååº”æ€§é«“ç³»é€ è¡€å¯¼è‡´å°é¼ å’Œäººç±»å…ç–«æŠ‘åˆ¶æ€§ä¸­æ€§ç²’ç»†èƒæ ·å•æ ¸ç»†èƒçš„æ‰©å¢ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304626">GSE304626 CXCL10/CXCR3è½´å¯¹äºç»´æŒä¸‰é˜´æ€§ä¹³è…ºç™Œçš„å…ç–«ä¼‘çœ è‡³å…³é‡è¦</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291577">GSE291577 èŠ±ç²‰å‘è‚²ä¸­å…·æœ‰åŠŸèƒ½ä½œç”¨çš„siRNAçš„é•¿è·ç¦»è¿è¾“[RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289883">è‚ºç§»æ¤å°é¼ çš„GSE289883å•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315740">GSE315740 æœ‰æ°§è¿åŠ¨å¯¹æ…¢æ€§åº”æ¿€è¯±å¯¼çš„é’å°‘å¹´å°é¼ æŠ‘éƒæ ·è¡Œä¸ºå’Œæµ·é©¬è½¬å½•ç»„çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315736">GSE315736 PTP1BæŠ‘åˆ¶é€šè¿‡å¢å¼ºSYKä¿¡å·ä¼ å¯¼ä¿ƒè¿›é˜¿å°”èŒ¨æµ·é»˜ç—…æ¨¡å‹ä¸­çš„å°èƒ¶è´¨ç»†èƒåå™¬ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315246">GSE315246 é€šè¿‡ FAP é¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [Xenium åŸä½]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314854">GSE314854 é€šè¿‡FAPé¶å‘å…ç–«ç–—æ³•æ²»ç–—åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314600">GSE314600 é€šè¿‡FAPé¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [SMC_Foam_Cell]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314598">GSE314598 é€šè¿‡ FAP é¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [å°é¼ ä¸»åŠ¨è„‰ BiTE]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314596">GSE314596 é€šè¿‡ FAP é¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [Human_CITEseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314595">GSE314595 é€šè¿‡ FAP é¶å‘å…ç–«ç–—æ³•é¶å‘åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ä¸­å—è°ƒæ§çš„è¡€ç®¡å¹³æ»‘è‚Œç»†èƒ [Foam_Cell]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306867">GSE306867 PAR1æ¿€é…¶å®¶æ—çš„ä¸¤ä¸ªæˆå‘˜PAR1bå’ŒPAR1aä¹‹é—´å­˜åœ¨éšæ€§å†—ä½™ï¼Œè¿™ç§å†—ä½™ä¸PAR1bæ•²é™¤å°é¼ çš„å­˜æ´»æœ‰å…³</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200898">GSE200898 å°é¼ æ»‘è†œå•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200283">GSE200283 å°é¼ æ»‘è†œæ‰¹é‡ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318090">GSE318090 Functional architecture of cardiac TF regulatory landscapes in control of mammalian heart development</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318002">GSE318002 å•ç»†èƒåˆ†è¾¨ç‡ä¸‹å‘è‚²ä¸­é¸¡ä¸‰å‰ç¥ç»èŠ‚çš„ç»†èƒå¤šæ ·æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317933">GSE317933 è‹¦å‚è‹·é€šè¿‡é¶å‘DDX5/c-Mycè½´æŠ‘åˆ¶è›‹ç™½è´¨åˆæˆæ¥æŠ‘åˆ¶æ€¥æ€§é«“ç³»ç™½è¡€ç—…</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317744">GSE317744 èƒ¸è…º CD11c+ ç»†èƒ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289429">GSE289429 è‚¿ç˜¤æŠ‘åˆ¶å› å­ STAG2 ä¸ DREAM ååŒä½œç”¨ï¼Œç»´æŒå°¿è·¯ä¸Šçš®çš„é™æ­¢çŠ¶æ€ [Hi-C]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288712">GSE288712 è‚¿ç˜¤æŠ‘åˆ¶å› å­STAG2ä¸DREAMååŒä½œç”¨ï¼Œç»´æŒå°¿è·¯ä¸Šçš®ç»†èƒçš„é™æ­¢çŠ¶æ€ã€‚</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-03 21:53</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week062026/ rel=tag>Week062026</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2026-02-02/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-02</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2026-02-05/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-05</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-11/>ç§‘ç ”æ—¥æŠ¥ 2026-02-11</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-10/>ç§‘ç ”æ—¥æŠ¥ 2026-02-10</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-09/>ç§‘ç ”æ—¥æŠ¥ 2026-02-09</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-08/>ç§‘ç ”æ—¥æŠ¥ 2026-02-08</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-07/>ç§‘ç ”æ—¥æŠ¥ 2026-02-07</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (104)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (104)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>